Aspirin Primary Heart Disease Prevention In Elderly Questioned In BMJ Study
This article was originally published in The Tan Sheet
Executive Summary
Broad application of low-dose aspirin therapy for cardiac disease primary prevention may be inappropriate for populations over age 70, authors of a British Medical Journal study say
You may also be interested in...
Supplement GMP Warning Letters Make Modest Debut In 2010
Finalization of a settlement between the Federal Trade Commission and Rexall Sundown regarding unsupported cellulite treatment claims for the firm's Cellasene dietary supplement hinges upon approval of two related class action settlements pending in California and Florida, according to FTC
In Brief
Combe sells most of its OTC brands
People In Brief
Perrigo promotes in pricing, planning